DUBLIN, Oct. 19, 2023 /PRNewswire/ -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key ...

Monoclonal Antibodies: A Transformative Force in Biopharmaceuticals, Driving Growth in Antibody Discovery Services and Platforms

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody ...

Global Antibody Discovery Services Market Set To Soar Past $1.6 Billion By 2023: Aiding Pharmaceutical Efficiency Through Outsourcing

Danish health tech company Radiobotics has appointed Peter Ulvskjold as its new CEO to take charge of the company’s global commercialisation. He comes with more than 20 years of pharma and med tech experience. Radiobotics has developed innovative AI ...

Denmark: Radiobotics appoints new CEO to take the company global

CIT-013 is under clinical development by Citryll and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase I drugs for Rheumatoid Arthritis have a 71% phase transition success rate (PTSR) indication benchmark for progressing into ...

CIT-013 by Citryll for Rheumatoid Arthritis: Likelihood of Approval

CIT-013 is under clinical development by Citryll and currently in Phase I for Colitis. According to GlobalData, Phase I drugs for Colitis does not have sufficient historical data to build an indication benchmark PTSR for Phase I. GlobalData uses ...

CIT-013 by Citryll for Colitis: Likelihood of Approval

CIT-013 is under clinical development by Citryll and currently in Phase I for Vasculitis. According to GlobalData, Phase I drugs for Vasculitis have an 81% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData ...

CIT-013 by Citryll for Vasculitis: Likelihood of Approval

Cofinimmo, the Euronext Brussels-listed real estate investor, is to build an eco-friendly nursing and care home in the Netherlands. The investment budget amounts to approximately €9m (US$9.5m), of which €3m is earmarked for spending in 2023. Modern and ...

The Netherlands: Cofinimmo to build eco-friendly nursing and care home

Privately-held Dutch immune-mediated inflammatory diseases company Citryll is the latest stop for experienced biotech chief executive Eduardo Bravo. Seattle, USA-based Alpine Immune Sciences, an immunotherapy company developing innovative treatments for ...

Biotechnology - Inflammatory diseases

DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insight, 2023,” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Systemic Lupus Erythematosus ...

Systemic Lupus Erythematosus Pipeline, Clinical and Non-Clinical Stage Products, and FDA Approvals 2023 (Updated)

Privately-held Dutch immune-mediated inflammatory diseases company Citryll is the latest stop for experienced biotech chief executive Eduardo Bravo. US biotech Selecta Biosciences is to freeze investment on all pipeline assets except SEL-212, which is ...

One to Watch Companies - Inflammatory diseases, TiGenix

Citryll

Citryll BV is a private pharmaceutical company based in Oss, the Netherlands that is dedicated to the development and commercialization of therapeutics that target NETosis and NETs. Target diseases include SLE, RA, vasculitis, cancer and fibrosis.

CITRYLL

citryll.com

employees

Since 2015

COMPANY RANKING

CITRYLL

EVERGREEN INDEX #2954

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Citryll

Citryll WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

CITRYLL

citryll.com

employees

Since 2015

COMPANY RANKING

CITRYLL

EVERGREEN INDEX #2954

RELATED COMPANIESRANK

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Citryll

Citryll WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!